Amy N. Sexauer, MD, PhD

Dr. Sexauer studies the process of normal hematopoietic differentiation and its perturbations in both myeloid and lymphoid malignancies. Her goal as an academic physician-scientist is to continue to develop new combination therapies for children with high-risk leukemias to improve survival and minimize long-term toxicity.